Clinical Trial Update: High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose folic acid to prevent colorectal cancer recurrence in patients who had polyps surgically removed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• High-Dose Folic Acid (folic acid)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED